Design of OASIS-1 and-2: Phase 3 trials to assess the efficacy and safety of elinzanetant for the treatment of vasomotor symptoms related to menopause
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要